Resources
"Working with Innovaderm for our alopecia areata trial has been a smooth and exceptional experience (...)” - An Inmagene Biopharmaceuticals Testimonial
Our remarkable team has received high praise from yet another satisfied customer! "Working with Innovaderm for our alopecia areata trial has been a smooth and exceptional experience, marked by their extensive expertise, proactive approach, and seamless collaboration." Duong Nguyen, Head of Clinical Operations at Inmagene Biopharmaceuticals. “Innovaderm’s profound understanding of alopecia areata and their forward-thinking […]
"Collaborative Excellence: A Testament to our Shared Success with Innovaderm!" - A Ventyx Biosciences Testimonial
Innovaderm is excited to share a glowing testimonial from Ventyx Biosciences! "We would like to express our gratitude for the exceptional partnership we’ve had with Innovaderm. Our collaboration on a phase 2 study for moderate to severe plaque psoriasis was nothing short of remarkable. The expertise and motivation Innovaderm brought to the table were pivotal […]
Testimonial: "Thanks to Innovaderm's adaptive approach, we sailed through our trial with ease!"
Innovaderm is proud of its partnership with BioMimetix JV, LLC. Read what their Clinical Operation Director has to share on our expertise: “Our collaboration with Innovaderm has been truly outstanding. We initially sought their expertise in an atopic dermatitis trial management and right from the start, the team impressed us with their proficiency and professionalism. […]
Nimbus Testimonial
Innovaderm is proud of its partnership with Nimbus Therapeutics for an investigational oral TYK2 inhibitor, in a Phase 2b trial for patients with moderate-to-severe psoriasis. Innovaderm’s reputed teams once again proved their expertise throughout the whole project, from the study design all the way to the trial reports, under tight timelines. “There are many CRO […]
Innovaderm, a Key Collaborator in Clinical and Study Development for Recently Published Phase 1 Atopic Dermatitis Study
[MONTREAL, QUEBEC — December 19, 2023] Allergy recently published RAPT Therapeutics’ phase 1a/1b atopic dermatitis (AD) study, in which Innovaderm Research was a key partner, serving as the contract research organization (CRO). This was a first-in-human and proof of concept randomized, placebo-controlled Phase 1a/1b monotherapy study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and CCR4 […]
Generalized Pustular Psoriasis (GPP) Rescue Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully transitioned this rescue study from another CRO and this resulted in: More than doubled patient enrollment in 1 month Started enrollment 1 month faster than initial projection All 5 newly added sites were actively recruiting Study Characteristics Study Phase: IIa Study […]
Hidradenitis Suppurativa (HS) Case study
Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this HS study and this resulted in: Enrollment completed 3 months ahead of schedule Study Characteristics Study Phase: II Patient Population: Hidradenitis Suppurativa IP Route of Administration: Systemic - Subcutaneous Site distribution: 25 in North America and 16 in Europe […]
Palmoplantar Pustulosis (PPP) Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this PPP study and this resulted in: Enrollment completed 3 weeks ahead of schedule; Successful study and satisfied sponsor Study Characteristics Study Phase: II Patient Population: Palmoplantar pustulosis IP Route of Administration: Systemic Sites Distribution: 17 sites in 2 countries […]
Notalgia Paresthetica (NP) Case Study
Click here for a PDF version of this case study Study Characteristics Study Phase: II Patient Population: 126 patients with Notalgia Paresthetica (NP) (Pruritus associated with NP) IP Route of Administration: Systemic (oral) Site Distribution: 33 sites (USA and Canada) Study Procedures: Photographs, Pharmacokinetics, Electrocardiograms Study Challenges Patient awareness: Challenge in advertisement as […]
Alopecia Areata (AA) Case Study
Click here for a PDF version of this case study Outcomes Innovaderm’s outstanding support on this alopecia areata study resulted in a rapid increase in enrollment rates and the successful management of this trial Study Characteristics Study Phase: II Patient Population: Alopecia Areata IP Route of Administration: Systemic Sites distribution: 12 sites (CAD-USA) Complex […]
Atopic Dermatitis (AD) Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this AD study and this resulted in: Enrollment completed 2 months earlier than planned; Innovaderm CRU recruited 33% of patients Study Characteristics Study Phase: Ib Patient Population: 36 subjects with moderate to severe AD IP Route of Administration: Systemic - […]
Acne Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this acne study and this resulted in: Enrollment completed 1 month earlier than planned Study Characteristics Study Phase: II Patient Population: Acne vulgaris (enrolling pediatrics & adults) IP Route of Administration: Systemic Sites distribution: 15 sites (USA) Study […]
Palmoplantar Pustulosis (PPP) Rescue Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully transitioned this rescue study from another CRO and this resulted in: Increase in enrollment of over 10x Tripled site performance post transition On-time patient recruitment Study Characteristics Study Phase: II Study Status: Rescue study Patient Population: Palmoplantar pustulosis (PPP) IP Route […]
